All News

The FDA-approved topical and oral agent is currently indicated for adult patients with patterned alopecia.

Triona Schmelter discusses Opill’s availability, pricing, effectiveness, safety, and impact on addressing barriers to contraceptive access.

Laura Brown, MS, RDN, LDN, discusses the importance of National Nutrition Month, collaborating with pharmacists, promoting sustainable eating habits, and overcoming common nutrition misconceptions

Mila Felder, MD, FACEP, discusses Advocate Aurora Health’s approach to addressing burnout among health care professionals in health care systems.

The disease is complex, but many opportunities exist for pharmacist intervention.

Chimeric antigen receptor T-cell therapies were associated with higher incidences, grades of severity, and longer duration of cytokine release syndrome compared with bispecific antibodies.

Investigators found that 1,1,1 trichloroethane; 2-nitropropane; and 2,4,6 trichlorophenol were significantly associated with asthma symptoms for 3 exposure periods.

In a phase 1/2 clinical trial, lisocabtagene maraleucel helped patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) achieve complete response rates.

The study showed no clinical differences for remission or asthma at age 28 years based on lung function, body mass index, daily smoking, exposure to parental tobacco smoke, or house dampness .

Their expansive scope of services can ultimately help to elevate the work of the entire community pharmacy.

Compared to placebo, risankizumab significantly reduced symptom severity for patients with moderate to severe disease.

Women who have longer ovarian function and enter menopause later in life tend to live longer, according to women’s health researcher.

The drug is the first FDA-approved agent for treating hepatorenal syndrome.

Amina Abubakar, PharmD, AAHIVP, discussed her work throughout Africa and particularly in Kenya.

The platform is a first-of-its-kind therapeutic approach to promote remyelination among individuals with relapsing/remitting multiple sclerosis.

LSD d-tartrate (MM-120) showed rapid improvements in patients with generalized anxiety disorder by day 2 of the study.

Results from the phase 3 RATIONALE 302 trial showed tislelizumab-jsgr prolonged survival compared to chemotherapy in patients who received prior systemic treatment.

The accelerated approval of resmetirom, a once-daily, oral thyroid hormone receptor-β agonist, is the first treatment available for patients with this disease.

This finding was evident in both examined groups and regardless of the patients' B-cell maturation antigen-directed therapy status.

Raj Gupta, DC, discusses holistic approaches to managing type 2 diabetes without medication by addressing root causes like diet, toxins, and stress.

The drug is indicated for patients 5 years of age and older with progressive familial intrahepatic cholestasis and cholestatic pruritus in pediatric patients with Alagille syndrome.

Rep. Buddy Carter (R-Ga.) will be giving remarks at its upcoming Congressional Pharmacy Fly-In.

The tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.

At 4 months, 75% of participants achieved remission and no longer showed signs of depression symptoms in a phase 2 clinical trial.

During a time of staff shortages and increasing stress, the need to have an efficient workflow is of vital importance.

Antimicrobial stewardship is crucial for all health care professionals—not just those in a hospital setting

Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.